NASDAQ:IRON | Insider Transactions — Page 4 | Disc Medicine, Inc.

IRON Insider Transactions — Page 4

681 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 301–400; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
White William RichardDirector2024-07-01Sale74.0$46.45
White William RichardDirector2024-07-01Sale109.0$45.92
White William RichardDirector2024-07-01Sale18.0$45.07
Bitterman KevinDirector2024-06-17Purchase222,223.0$36.0
Ashiya MonaDirector2024-06-17Purchase10,986.0$36.0
Ashiya MonaDirector2024-06-17Purchase43,944.0$36.0
Ashiya MonaDirector2024-06-17Purchase28,404.0$36.0
ORBIMED ADVISORS LLCDirector2024-06-17Purchase10,986.0$36.0
OrbiMed Capital GP VI LLCDirector2024-06-17Purchase10,986.0$36.0
OrbiMed Genesis GP LLCDirector2024-06-17Purchase10,986.0$36.0
OrbiMed Capital GP VIII LLCDirector2024-06-17Purchase10,986.0$36.0
ORBIMED ADVISORS LLCDirector2024-06-17Purchase43,944.0$36.0
OrbiMed Capital GP VI LLCDirector2024-06-17Purchase43,944.0$36.0
OrbiMed Genesis GP LLCDirector2024-06-17Purchase43,944.0$36.0
OrbiMed Capital GP VIII LLCDirector2024-06-17Purchase43,944.0$36.0
ORBIMED ADVISORS LLCDirector2024-06-17Purchase28,404.0$36.0
OrbiMed Capital GP VI LLCDirector2024-06-17Purchase28,404.0$36.0
OrbiMed Genesis GP LLCDirector2024-06-17Purchase28,404.0$36.0
OrbiMed Capital GP VIII LLCDirector2024-06-17Purchase28,404.0$36.0
White William RichardDirector2024-06-03Sale95.0$36.72
White William RichardDirector2024-06-03Sale1,755.0$36.1
White William RichardDirector2024-06-03Sale107.0$35.15
White William RichardDirector2024-05-01Sale39.0$29.11
White William RichardDirector2024-05-01Sale162.0$28.52
White William RichardDirector2024-04-11Sale78.0$32.18
White William RichardDirector2024-04-11Sale2,482.0$31.79
Bitterman KevinDirector2024-03-05Sale26,157.0$73.5
Bitterman KevinDirector2024-01-23Sale20,000.0$67.65
Bitterman KevinDirector2024-01-23Sale82,500.0$67.65
Atlas Venture Fund X, L.P.TenPercentOwner2024-01-23Sale20,000.0$67.65
Atlas Venture Associates X, LLCTenPercentOwner2024-01-23Sale20,000.0$67.65
ATLAS VENTURE ASSOCIATES X, L.P.TenPercentOwner2024-01-23Sale20,000.0$67.65
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2024-01-23Sale20,000.0$67.65
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2024-01-23Sale20,000.0$67.65
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2024-01-23Sale20,000.0$67.65
Atlas Venture Opportunity Fund II, L.P.TenPercentOwner2024-01-23Sale20,000.0$67.65
Atlas Venture Associates Opportunity II, LLCTenPercentOwner2024-01-23Sale20,000.0$67.65
Atlas Venture Associates Opportunity II, LPTenPercentOwner2024-01-23Sale20,000.0$67.65
Atlas Venture Fund X, L.P.TenPercentOwner2024-01-23Sale82,500.0$67.65
Atlas Venture Associates X, LLCTenPercentOwner2024-01-23Sale82,500.0$67.65
ATLAS VENTURE ASSOCIATES X, L.P.TenPercentOwner2024-01-23Sale82,500.0$67.65
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2024-01-23Sale82,500.0$67.65
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2024-01-23Sale82,500.0$67.65
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2024-01-23Sale82,500.0$67.65
Atlas Venture Opportunity Fund II, L.P.TenPercentOwner2024-01-23Sale82,500.0$67.65
Atlas Venture Associates Opportunity II, LLCTenPercentOwner2024-01-23Sale82,500.0$67.65
Atlas Venture Associates Opportunity II, LPTenPercentOwner2024-01-23Sale82,500.0$67.65
Atlas Venture Fund X, L.P.TenPercentOwner2024-01-23Sale47,500.0$67.65
Atlas Venture Associates X, LLCTenPercentOwner2024-01-23Sale47,500.0$67.65
ATLAS VENTURE ASSOCIATES X, L.P.TenPercentOwner2024-01-23Sale47,500.0$67.65
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2024-01-23Sale47,500.0$67.65
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2024-01-23Sale47,500.0$67.65
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2024-01-23Sale47,500.0$67.65
Atlas Venture Opportunity Fund II, L.P.TenPercentOwner2024-01-23Sale47,500.0$67.65
Atlas Venture Associates Opportunity II, LLCTenPercentOwner2024-01-23Sale47,500.0$67.65
Atlas Venture Associates Opportunity II, LPTenPercentOwner2024-01-23Sale47,500.0$67.65
Bitterman KevinDirector2024-01-10Sale20,000.0$64.0
Atlas Venture Fund X, L.P.TenPercentOwner2024-01-10Sale20,000.0$64.0
Atlas Venture Associates X, LLCTenPercentOwner2024-01-10Sale20,000.0$64.0
ATLAS VENTURE ASSOCIATES X, L.P.TenPercentOwner2024-01-10Sale20,000.0$64.0
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2024-01-10Sale20,000.0$64.0
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2024-01-10Sale20,000.0$64.0
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2024-01-10Sale20,000.0$64.0
Atlas Venture Fund X, L.P.TenPercentOwner2024-01-10Sale30,000.0$64.0
Atlas Venture Associates X, LLCTenPercentOwner2024-01-10Sale30,000.0$64.0
ATLAS VENTURE ASSOCIATES X, L.P.TenPercentOwner2024-01-10Sale30,000.0$64.0
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2024-01-10Sale30,000.0$64.0
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2024-01-10Sale30,000.0$64.0
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2024-01-10Sale30,000.0$64.0
ORBIMED ADVISORS LLCDirector2023-12-18Sale1,724.0$59.24
OrbiMed Capital GP VI LLCDirector2023-12-18Sale1,724.0$59.24
OrbiMed Genesis GP LLCDirector2023-12-18Sale1,724.0$59.24
OrbiMed Capital GP VIII LLCDirector2023-12-18Sale1,724.0$59.24
Ashiya MonaDirector2023-12-18Sale1,724.0$59.24
Ashiya MonaDirector2023-12-14Sale57,100.0$56.75
Ashiya MonaDirector2023-12-14Sale147,600.0$56.75
Ashiya MonaDirector2023-12-14Sale228,500.0$56.75
ORBIMED ADVISORS LLCDirector2023-12-14Sale57,100.0$56.75
OrbiMed Capital GP VI LLCDirector2023-12-14Sale57,100.0$56.75
OrbiMed Genesis GP LLCDirector2023-12-14Sale57,100.0$56.75
OrbiMed Capital GP VIII LLCDirector2023-12-14Sale57,100.0$56.75
ORBIMED ADVISORS LLCDirector2023-12-14Sale147,600.0$56.75
OrbiMed Capital GP VI LLCDirector2023-12-14Sale147,600.0$56.75
OrbiMed Genesis GP LLCDirector2023-12-14Sale147,600.0$56.75
OrbiMed Capital GP VIII LLCDirector2023-12-14Sale147,600.0$56.75
ORBIMED ADVISORS LLCDirector2023-12-14Sale228,500.0$56.75
OrbiMed Capital GP VI LLCDirector2023-12-14Sale228,500.0$56.75
OrbiMed Genesis GP LLCDirector2023-12-14Sale228,500.0$56.75
OrbiMed Capital GP VIII LLCDirector2023-12-14Sale228,500.0$56.75
Bitterman KevinDirector2023-12-14Sale120.0$59.74
Bitterman KevinDirector2023-12-14Sale20,429.0$58.27
Atlas Venture Fund X, L.P.TenPercentOwner2023-12-14Sale120.0$59.74
Atlas Venture Associates X, LLCTenPercentOwner2023-12-14Sale120.0$59.74
ATLAS VENTURE ASSOCIATES X, L.P.TenPercentOwner2023-12-14Sale120.0$59.74
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2023-12-14Sale120.0$59.74
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2023-12-14Sale120.0$59.74
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2023-12-14Sale120.0$59.74
Atlas Venture Fund X, L.P.TenPercentOwner2023-12-14Sale180.0$59.74
Atlas Venture Associates X, LLCTenPercentOwner2023-12-14Sale180.0$59.74
ATLAS VENTURE ASSOCIATES X, L.P.TenPercentOwner2023-12-14Sale180.0$59.74